medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2009, Number 3

<< Back Next >>

Rev Biomed 2009; 20 (3)

Chagas disease in Bolivia: a brief review of the urban phenom

Araújo-Jorge TC, Medrano-Mercado N

Language: English
References: 48
Page: 236-244
PDF size: 125.47 Kb.


ABSTRACT

Chagas disease is a major public health problem in Latin America. At present, Bolivia has the highest rate of vector and congenital transmission, and the old rural profile of the disease is changing rapidly into urban. Recent epidemiologic data indicates that all the capital cities of the 9 Bolivian departments still have new cases of Chagas disease in children under fifteen years. However, good news came from Bolivia: the Chagas control program has reduced importantly the rate of infection. We present a brief review on the Chagas disease literature concerning Bolivia and discuss the present problems and challenges in epidemiology, vector distribution, clinical management, congenital transmission and drug treatment.


REFERENCES

  1. Moncayo A, Silveira AC. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem I Oswaldo Cruz. 2009; 104 Suppl 1:17-30.

  2. Noireau F. La enfermedad de Chagas y sus particularidades epidemiológicas en Bolivia. In R Al Cassab, F Noireau F, G Guillén (eds.), Chagas, la enfermedad en Bolivia: conocimientos científicos al inicio del programa de control (1998-2002), Primera, La Paz, 1999; p. 17-47.

  3. Guillén G. 2002; El control de la enfermedad de Chagas en Bolivia. In AC Silveira (org.) El control de la enfermedad de Chagas en los países del Cono Sur de América: historia de una iniciativa internacional, 1991/2001, PAHO E-book. Available from: http://www.paho.org/portuguese/ad/dpc/cd/dch-historia-incosur. PDF.

  4. WHO - World Health Organization 2002; Control of Chagas Disease, WHO Technical Report Series 811, Geneva. Available from: http://whqlibdoc.who.int/trs/WHO_TRS_905.pdf.

  5. Carrasco R, Miguez H, Camacho C, Echalar L, Revollo S, Ampuero T, Dedet JP. Prevalence of Trypanosoma cruzi in blood banks of seven departments of Bolivia. Mem I Oswaldo Cruz. 1990; 85: 69-73.

  6. PAHO - Pan American Health Organization 1998. Report of the VII Meeting of the Intergovernmental Commission of the Southern Cone Initiative, Buenos Aires, Argentina. OPS/HPC/HCT/98.114, Washington DC.

  7. Arata AA, Balderrama F, Bermudez H, Navin T, Ormsby G, Torrico F, Velarde R. Trabajo de la SNS CCH/Programa Piloto de Control de Chagas. La Paz, Bolivia, Ministerio del Desarollo Humano, Secretaría Nacional de Salud, 1994; 94 pp.

  8. Medrano-Mercado N, Ugarte-Fernandez R, Butrón V, Uber-Busek S, Guerra HL, Araújo-Jorge TC, et al. Urban transmission of Chagas disease in Cochabamba, Bolivia. Mem I Oswaldo Cruz 2008; 103:423-30.

  9. Pless M, Juranek D, Kozarsky P, Steurer F, Tapia G, Bermudez H. The epidemiology of Chagas disease in a hyperendemic area of Cochabamba, Bolivia: A clinical study including electrocardiography, seroreactivity to Trypanosoma cruzi, xenodiagnosis, and domiciliary triatomine distribution. Am J Trop Med Hyg 1992; 47:539-546.

  10. Brenière SF , Bosseno MF, Noireau F, Yacsik N, Liegeard P, Aznar C, et al. Integrate study of a Bolivian population infected by Trypanosoma cruzi, the agent of Chagas Disease. Mem I Oswaldo Cruz 2002; 97:289-295.

  11. Briceño-León R. Chagas disease in the Americas: an ecohealth perspective. Cad Saúde Pública 2009; 25 Suppl 1:S71-82.

  12. Albarracin-Veizaga H, Carvalho ME , Nascimento EMM, Rodrigues VLCC, Casanova C, Barata JMS. Chagas disease in an area of recent occupation in Cochabamba, Bolivia. Rev Saúde Pública 1999; 33:230-6.

  13. Bowman NM, Kawai V, Levy MZ, Cornejo del Carpio JG, Cabrera L, Delgado F, et al. Chagas disease transmission in periurban communities of Arequipa, Peru. Clin Infect Dis 2008; 46:1822-8.

  14. Lorca M, García A, Contreras MC, Schenone H, Rojas A. Evaluation of a Triatoma infestans elimination program by the decrease of Trypanosoma cruzi infection frequency in children younger than 10 years, Chile,1991-1998. Am J Trop Med Hyg 2001; 65:861-4.

  15. Chippaux JP, Postigo JR, Santalla JA, Schneider D, Brutus L. Epidemiological evaluation of Chagas disease in a rural area of southern Bolivia. Trans R Soc Trop Med Hyg 2008; 102:578-84.

  16. Schmunis GA. Epidemiology of Chagas disease in nonendemic countries: the role of international migration. Mem I Oswaldo Cruz 2007; 102(Suppl. I): 75-85

  17. INE - Instituto Nacional de Estadística 2001. Censo de Población y Vivienda. Bolivia. Available from: http://www.ine.gov.bo/cgibin/Redatam/RG4WebEngine.exe/PortalAction.

  18. Bailey-Lazcano R C, Trewhella-Fernandez. Identidad familiar, migración y desnutrición: las vicisitudes de la dinámica identidaria familiar ante la migración: identidad familiar y desnutrición, Thesis, UMSS, Cochabamba, Bolivia, 1998; 78 pp.

  19. Ledo MC, Zelada O. Población, migración y empleo en Cochabamba, Centro de Estudios de la Población, CEP, Cochabamba, 1989; 78 pp.

  20. Blanes J. Bolivia: las áreas metropolitanas en perspectiva de desarrollo regional. Rev Eure (Santiago de Chile) 2006; 32:21-36.

  21. Calderon GF, Toranzos C. Urbanización y Etnicidad. El caso de La Paz. Cochabamba, CERES, 1984; 65 pp.

  22. Gomes YM, Lorena VMB, Luquetti AO. Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? Mem I Oswaldo Cruz 2009; 104(Suppl. I): 115-121.

  23. Chippaux JP, Santalla JA, Postigo JR, Romero M, Salas Clavijo NA, Schneider D, et al. Sensitivity and specificity of Chagas Stat-Pak test in Bolivia. Trop Med Int Health 2009; 14:732-5.

  24. Yun O, Lima MA, Ellman T, Chambi W, Castillo S, Flevaud L, et al. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of médecins sans frontières. PLoS Negl Trop Dis 2009; 3:e488.

  25. Azogue E. Women and congenital Chagas’ disease in Santa Cruz, Bolivia: epidemiological and sociocultural aspects. Soc Sci Med 1993; 37:503-11.

  26. Brutus L, Schneider D, Postigo J, Romero M, Santalla J, Chippaux JP. Congenital Chagas disease: diagnostic and clinical aspects in an area without vectorial transmission, Bermejo, Bolivia. Acta Trop 2008; 106:195-9.

  27. Torrico F, Alonso-Vega C, Suarez E, Rodriguez P, Torrico MC, Dramaix M, et al. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg 2004; 70:201-9.

  28. Torrico F, Vega CA, Suarez E, Tellez T, Brutus L, Rodriguez P, et al. Are maternal re-infections with Trypanosoma cruzi associated with higher morbidity and mortality of congenital Chagas disease? Trop Med Int Health 2006; 11:628-35.

  29. Torrico F, Castro M, Solano M, Rodriguez P, Torrico MC, Truyens C, et al. Effects of maternal infection with Trypanosoma cruzi in pregnancy development and in the newborn infant. Rev Soc Bras Med Trop. 2005; 38 Suppl 2:73-6.

  30. Virreira M, Truyens C, Alonso-Vega C, Brutus L, Jijena J, Torrico F, et al. Comparison of Trypanosoma cruzi lineages and levels of parasitic DNA in infected mothers and their newborns. Am J Trop Med Hyg 2007; 77:102-6.

  31. Torrico MC, Solano M, Guzmán JM, Parrado R, Suarez E, Alonzo-Vega C, et al. Estimation of the parasitemia in Trypanosoma cruzi human infection: high parasitemias are associated with severe and fatal congenital Chagas disease Rev Soc Bras Med Trop 2005; 38 Suppl 2:58-61.

  32. Alonso-Vega C, Hermann E, Truyens C, Rodriguez P, Torrico MC, Torrico F, Carlier Y. Immunological status of mothers infected with Trypanosoma cruzi. Rev Soc Bras Med Trop 2005; 38 Suppl 2:101-4.

  33. Suárez E, Alonso-Vega C, Torrico F, Córdova M. Integral treatment of congenital Chagas disease: the Bolivian experience Rev Soc Bras Med Trop 2005; 238 Suppl 2:21-3.

  34. Billot C, Torrico F, Carlier Y. Cost effectiveness study of a control program of congenital Chagas disease in Bolivia. Rev Soc Bras Med Trop 2005; 38 Suppl 2:108-13.

  35. Salgado JA, Garcez PN, Oliveira CA, Gallizi I. Revisão clínica atual do primeiro caso humano descrito de doença de Chagas. Rev Inst Med Trop 1962; 4:330-337.

  36. Barretto ACP, Ianni BM. The undetermined form of Chagas’ heart disease: concept and forensic implications. Sao Paulo Med J/RPM 1995; 113:797-801.

  37. Secretaria de Vigilância em Saúde do Ministério Da Saúde. Brasil, Consenso brasileiro em Doença de Chagas. Rev Soc Bras Med Trop 2005; 38 (Suplemento III).

  38. Rassi Jr A, Rassi A, Marin-Neto JÁ. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem I Oswaldo Cruz 2009; 104(Suppl. I):152-158.

  39. Rocha MOC, Nunes MCP, Ribeiro AL. Morbidity and prognostic factors in chronic chagasic cardiopathy. Mem I Oswaldo Cruz 2009; 104(Suppl. I):159-166.

  40. Jannin J, Villa L. An overview of Chagas disease treatment. Mem I Oswaldo Cruz 2007; 102(Suppl. I): 95-97.

  41. Marin-Neto JÁ, Rassi Jr A, Avezum Jr A, Mattos AC, Rassi A. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem I Oswaldo Cruz 2009; 104(Suppl. I): 319-324.

  42. Oliveira Jr W. All-around care for patients with Chagas disease: a challenge for the XXI century. Mem Inst Oswaldo Cruz 2009; 104(Suppl. I): 181-186.

  43. Coura JR, Dias JCP. Epidemiology, control and surveillance of Chagas disease-100 years after its discovery. Mem I Oswaldo Cruz 2009; 104(Suppl. I):31-40.

  44. Noireau F. Wild Triatoma infestans, a potential threat that needs to be monitored. Mem I Oswaldo Cruz 2009; 104(Suppl. I): 60-64.

  45. Fitzpatrick S, Feliciangeli MD, Sanchez-Martin MJ, Monteiro FA, Miles MA. Molecular genetics reveal that silvatic Rhodnius prolixus do colonise rural houses. PLoS Negl Trop Dis 2008; 2:e210.

  46. Araújo CA, Waniek PJ, Jansen AM. An overview of Chagas disease and the role of triatomines on its distribution in Brazil. Vector Borne Zoonotic Dis 2009; 9:227-234.

  47. Cabello CC, Cabello CF. Zoonoses with wildlife reservoirs: a threat to public health and the economy. Rev Med Chil 2008; 136:385-93.

  48. Click Lambert R, Kolivras KN, Resler LM, Brewster CC, Paulson SL. The potential for emergence of Chagas disease in the United States. Geospat Health 2008; 2:227-239.




2020     |     www.medigraphic.com